| Id |
Subject |
Object |
Predicate |
Lexical cue |
| SS1_23359648_2_0 |
186-208 |
expanded |
denotes |
nedaplatin/gemcitabine |
| SS2_23359648_2_0 |
210-212 |
abbr |
denotes |
NG |
| SS1_23359648_2_1 |
218-241 |
expanded |
denotes |
carboplatin/gemcitabine |
| SS2_23359648_2_1 |
243-245 |
abbr |
denotes |
CG |
| SS1_23359648_2_2 |
287-313 |
expanded |
denotes |
non-small cell lung cancer |
| SS2_23359648_2_2 |
315-320 |
abbr |
denotes |
NSCLC |
| SS1_23359648_7_0 |
691-714 |
expanded |
denotes |
objective response rate |
| SS2_23359648_7_0 |
716-719 |
abbr |
denotes |
ORR |
| SS1_23359648_8_0 |
762-787 |
expanded |
denotes |
progression-free survival |
| SS2_23359648_8_0 |
789-792 |
abbr |
denotes |
PFS |
| SS1_23359648_8_1 |
795-811 |
expanded |
denotes |
overall survival |
| SS2_23359648_8_1 |
813-815 |
abbr |
denotes |
OS |
| AE1_23359648_2_0 |
SS1_23359648_2_0 |
SS2_23359648_2_0 |
abbreviatedTo |
nedaplatin/gemcitabine,NG |
| AE1_23359648_2_1 |
SS1_23359648_2_1 |
SS2_23359648_2_1 |
abbreviatedTo |
carboplatin/gemcitabine,CG |
| AE1_23359648_2_2 |
SS1_23359648_2_2 |
SS2_23359648_2_2 |
abbreviatedTo |
non-small cell lung cancer,NSCLC |
| AE1_23359648_7_0 |
SS1_23359648_7_0 |
SS2_23359648_7_0 |
abbreviatedTo |
objective response rate,ORR |
| AE1_23359648_8_0 |
SS1_23359648_8_0 |
SS2_23359648_8_0 |
abbreviatedTo |
progression-free survival,PFS |
| AE1_23359648_8_1 |
SS1_23359648_8_1 |
SS2_23359648_8_1 |
abbreviatedTo |
overall survival,OS |
